| 000 | 01774 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516213631.0 | ||
| 264 | 0 | _c20140714 | |
| 008 | 201407s 0 0 eng d | ||
| 022 | _a2038-2529 | ||
| 024 | 7 |
_a10.1177/030089161410000218 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEsquerdo, Gaspar | |
| 245 | 0 | 0 |
_aDarbepoetin alfa administered once every three weeks for the treatment of anemia in elderly patients with non-myeloid tumors receiving chemotherapy. _h[electronic resource] |
| 260 |
_bTumori _c |
||
| 300 |
_a225-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnemia _xblood |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDarbepoetin alfa |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aErythropoietin _xadministration & dosage |
| 650 | 0 | 4 |
_aFatigue _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHematinics _xadministration & dosage |
| 650 | 0 | 4 |
_aHemoglobins _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDoménech, Mercedes | |
| 700 | 1 | _aLópez, Pilar | |
| 700 | 1 | _aPedro, Carme | |
| 700 | 1 | _aVilladiego, Kenny | |
| 700 | 1 | _aConstenla, Manuel | |
| 700 | 1 | _aSánchez-Rovira, Pedro | |
| 700 | 1 | _aGasquet, José A | |
| 700 | 1 | _aRodríguez, César A | |
| 773 | 0 |
_tTumori _gvol. 100 _gno. 2 _gp. 225-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/030089161410000218 _zAvailable from publisher's website |
| 999 |
_c23848529 _d23848529 |
||